StockData
NUMDOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Nu-Med Plus, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.01−0.00 (-8.16%)

Close on Oct 19, 2026

Market cap
$601.55K
P/E (TTM)
–
Dividend yield
–

About Nu-Med Plus

Surgical & Medical Instruments & Apparatus, SIC 3841

Nu-Med Plus, Inc. is a medical device company focused on the design, development, and commercialization of technologies utilizing nitric oxide in the medical field. The company develops proprietary formulations to generate nitric oxide gas on demand, eliminating the need for compressed gas cylinders. Its product pipeline includes hospital nitric oxide delivery devices for intensive care ventilator patients, clinical delivery systems for doctor offices and clinics, mobile rechargeable devices for inhalation therapy, disposable treatment units, and gas dilution systems for research applications. The company targets applications across hospital intensive care units, outpatient clinics, and research laboratories.

The company operates with two employees and relies on officers and consultants for its activities. Nu-Med Plus is headquartered in Salt Lake City, Utah, with executive offices located in Port Jefferson, New York. Its development activities are designed to serve markets in the United States and remote or developing areas internationally.

Summary of the business section of Nu-Med Plus's latest annual report, written by StockData.

Company profile

Company

Legal name
Nu-Med Plus, Inc.
Founded
2011
Headquarters
Port Jefferson, NY
Address
640 Belle Terre Rd. 2 E 11777
Phone
(631) 403-4337
Employees
2, Dec 31, 2025
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
Utah
Fiscal year ends
December 31
Auditor
Fruci & Associates II, PLLC, Spokane, Washington

Stock & identifiers

Ticker
NUMD
Exchange
OTC
Shares outstanding
84M, Aug 14, 2026
Public float
$3.24M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
SEC CIK
1543637
CUSIP
67021R104
ISIN
US67021R1041
EIN
45-3672530

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Fred TejadaSVP and Chief Geologist, Director16,381,250

Employees

Headcount reported in annual reports

“The Company currently has two employees and relies on its officers and consultants for most of its activities.”

Corporate history

Events identified from SEC filings